Single-dose oral treatment for gonorrhea effectively combats drug-resistant infections, clinical trial finds

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup